COA Statement on Departure of FDA Commissioner Scott Gottlieb, MD

March 6, 2019

“We are truly saddened by the departure of Scott Gottlieb, MD from the Food & Drug Administration (FDA).  The diversity of issues Commissioner Gottlieb tackled – including drug approvals, opioids, e-cigarettes/vaping, and more – and the modernization of the FDA were amazing.  During his brief tenure at the FDA, Dr. Gottlieb had to also deal with natural disasters and a government shutdown.  His leadership will be sorely missed, and Dr. Gottlieb will be difficult to replace.”

Ted Okon
Executive Director
Community Oncology Alliance (COA)